Cash crunch quells antibody litigation.
Mitchell
Peter
P
D000906:Antibodies; D001709:Biotechnology / Q000191:economics* / Q000331:legislation & jurisprudence*; D005249:Fees and Charges / Q000331:legislation & jurisprudence*; D005376:Financial Management; D005858:Germany; D007603:Jurisprudence; D008004:Licensure / Q000191:economics / Q000331:legislation & jurisprudence; D009426:Netherlands; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D019151:Peptide Library; D006113:United Kingdom; D014481:United States
D000906:Antibodies; D019151:Peptide Library